MBX Biosciences, Inc.
MBX
$32.45
-$2.91-8.23%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 82.73% | 42.55% | 41.37% | 306.98% | 242.43% |
| Total Receivables | 127.94% | 210.85% | 80.42% | 412.80% | 595.98% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 210.21% | 32.89% | 40.98% | -5.17% | -26.56% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 30.03% | 7.22% | 5.25% | 95.04% | 272.62% |
| Total Current Assets | 83.62% | 42.75% | 41.37% | 289.77% | 236.02% |
|
|
|||||
| Total Current Assets | 83.62% | 42.75% | 41.37% | 289.77% | 236.02% |
| Net Property, Plant & Equipment | 124.13% | 168.72% | 113.90% | 78.34% | 81.82% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1,058.00% | 666.00% | 0.00% | -98.18% | -97.13% |
| Total Assets | 84.08% | 43.42% | 41.67% | 268.18% | 226.51% |
|
|
|||||
| Total Accounts Payable | 64.29% | -44.20% | -24.67% | 78.95% | 32.82% |
| Total Accrued Expenses | 21.44% | 122.65% | 41.52% | 21.58% | 160.61% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 36.92% | 0.58% | -7.23% | -14.81% | -17.20% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 38.98% | 40.21% | 10.46% | 43.40% | 84.01% |
|
|
|||||
| Total Current Liabilities | 38.98% | 40.21% | 10.46% | 43.40% | 84.01% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 965.91% | 488.51% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -95.65% | -95.24% | -89.71% | -88.00% | -87.57% |
| Total Liabilities | 42.28% | 43.52% | 13.65% | 46.05% | 74.78% |
|
|
|||||
| Common Stock & APIC | 72.99% | 50.27% | 50.01% | 6,672.03% | 8,036.87% |
| Retained Earnings | -53.67% | -63.25% | -66.02% | -74.22% | -83.56% |
| Treasury Stock & Other | -1,243.40% | 420.00% | 45.28% | 173.33% | 1,866.67% |
| Total Common Equity | 85.95% | 43.42% | 42.81% | 323.98% | 383.48% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 85.95% | 43.42% | 42.81% | 323.98% | 383.48% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 85.95% | 43.42% | 42.81% | 302.48% | 239.67% |
|
|
|||||